Niche Differentiator Sotere Medical Solutions offers the world’s only noninvasive platform for diagnosing and monitoring early stage atherosclerosis, a strong differentiator to pursue partnerships with hospitals and vascular clinics seeking innovative cardiovascular risk assessment tools.

Early Stage Targeting The Soterogram’s ability to measure arterial elasticity and compliance enables early risk stratification for heart attack and cerebrovascular diseases, presenting upsell opportunities with preventive care programs, primary care networks, and wellness/health screening services.

Small but Scalable With a lean team and revenue under one million, there is an opportunity to position Sotere as a scalable, highly selective supplier for tiered deployments, training packages, and managed cloud services to reduce IT burden for prospective customers.

Technical Partnerships Current tech stack (Google Cloud, Lua, Nginx, OpenResty) suggests compatibility with cloud-based deployment, data analytics, and integration with hospital information systems; target health systems and EHR/EMR vendors for integration partnerships and joint go-to-market efforts.

Strategic Alliances Compare the modest scale to large device incumbents in the same space; identify collaboration or channel partners among mid-sized medical device distributors and cardiovascular specialty groups to accelerate adoption and expand geographic reach.